98 - Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Autor: Díez Campelo, M.E., Lorenzo, J.I., Itzykson, R., Rojas, S.M., Berthon, C., Pérez-Oteiza, J., Beyne-Rauzy, O., Bargay, J., Vey, N., Cedena, T., Park, S., Such, E., Bordessoule, D., Hernández Rivas, J.M., López Cadenas, F., Cañizo, M.C., Fenaux, P.
Zdroj: In Leukemia Research April 2017 55 Supplement 1:S61-S63
Databáze: ScienceDirect